Financing, Equity Capital Markets

OncoCyte Corporation

02/19
|
$40.3 Million
Piper Sandler served as left bookrunner for OncoCyte Corporation on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Life Sciences Tools & Diagnostics